Immunome Inc. (IMNM) Announces Proposed $200M Share Offering

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PTC
2. NVDA
3. PCVX
4. SPY
5. META
6. USO
7. MSFT
8. AMD
9. AMZN
10. ATH

Go back to Immunome Inc. (IMNM) Announces Proposed $200M Share Offering

Immunome Announces Proposed Public Offering of Common Stock

February 13, 2024 4:05 PM EST

BOTHELL, Wash.--(BUSINESS WIRE)-- Immunome, Inc. (Immunome) (Nasdaq: IMNM), a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies, today announced its plans to commence an underwritten public offering, subject to market and other conditions, to issue and sell $200.0 million of shares of its common stock. All of the shares are being offered by Immunome. In connection with the proposed offering, Immunome expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the public offering.... More